{
  "abstract": "Lung cancer screening (LCS) with low-dose CT has been proven to reduce lung cancer-specific mortality in high-risk individuals. However, there has been a lot of concern regarding false-positive scans requiring additional imaging follow-up or even biopsies. Reporting guidelines, such as those developed by the American College of Radiology (ACR Lung-RADS)1 or the British Thoracic Society (BTS),2 aim to reduce false positives and standardise nodule management. Among these guidelines, there is disagreement about how best to measure pulmonary nodules; some, such as the ACR, favour linear diameter measurement, while others, such as the BTS, favour volume measurement.",
  "authors": [
    {
      "affiliations": [
        "Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts, USA"
      ],
      "name": "Mark M Hammer"
    }
  ],
  "title": "Comparison of volume-based and diameter-based assessment of solid nodules in lung cancer screening",
  "uid": "57d8f85e-9478-56d9-9c95-4e5b4218cfd9"
}